3.28
1.55%
0.05
前日終値:
$3.23
開ける:
$3.18
24時間の取引高:
36,020
Relative Volume:
4.75
時価総額:
$33.26M
収益:
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
+5.47%
1か月 パフォーマンス:
+0.00%
6か月 パフォーマンス:
+0.00%
1年 パフォーマンス:
+0.00%
Grace Therapeutics Inc Stock (GRCE) Company Profile
GRCE を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
GRCE | 3.28 | 33.26M | 0 | 0 | 0 | 0.00 |
VRTX | 450.97 | 116.14B | 10.63B | -479.80M | -1.35B | 13.33 |
REGN | 738.00 | 81.10B | 13.85B | 4.65B | 3.32B | 35.06 |
ARGX | 605.92 | 36.23B | 1.86B | -40.29M | -1.28B | -4.16 |
ALNY | 244.89 | 31.59B | 2.09B | -332.26M | 16.06M | -4.14 |
BNTX | 113.13 | 27.12B | 3.30B | -501.07M | 1.03B | 11.54 |
Grace Therapeutics Inc (GRCE) 最新ニュース
Grace Therapeutics Reports Steady Progress and Financials - TipRanks
GRCE (Grace Therapeutics) Total Inventories : $0.00 Mil (As of Sep. 2024) - GuruFocus.com
GRCE: FY:25 Second Quarter Results - MSN
Twist Bioscience rises 13% on FQ4 earnings beats, 2025 revenue outlook - MSN
Altair Solutions Now Supported on NVIDIA Grace Hopper and Grace CPU Superchip Architectures - Yahoo Finance
Liquidia Corporation Reports Third Quarter 2024 Financial Results and Provides Corporate UpdateOn November 13, 2024, Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company focusing on innovative therapies for rare cardiopulmonary dise - Defense World
Horizon Space Acquisition I Corp. Approved for Listing on Nasdaq Capital Market - Defense World
Seres Therapeutics Receives Notification from Nasdaq Regarding Bid Price Requirement - Defense World
BioRestorative Therapies Provides Business Update and Financial Results for Q3 2024 - Defense World
Nikola Corporation Enters Material Definitive Agreements, Modifies Convertible Notes – 8-K Filing Highlights - Defense World
AgriFORCE Growing Systems Announces Strategic Shift Towards Sustainable Technology Initiatives - Defense World
Cognition Therapeutics Reports Financial Results for the Third Quarter 2024UNAUDITED – On November 13, 2024, Cognition Therapeutics, Inc. (NASDAQ: CGTX) disclosed its financial results for the third quarter ending September 30, 2024. Within the detai - Defense World
Digital Brands Group (NASDAQ: DBGI) Announces Strategic Partnership with VaynerCommerce - Defense World
MRC Global Inc. Enters into Fifth Amended and Restated Loan Agreement - Defense World
Air Industries Group to Release Financial Results for Q3 2024 - Defense World
Intevac (NASDAQ: IVAC) Enters into Letter Agreement with Palogic Value Management, L.P.Santa Clara, CA, November 13, 2024 – Intevac, Inc. (NASDAQ: IVAC) disclosed today in a Form 8-K filing that on November 8, 2024, the company entered into a letter - Defense World
Advance Auto Parts Enters Amendment to Credit Agreement - Defense World
Sound Point Meridian Capital, Inc. (NYSE: SPMC) Announces Financial Results for Quarter Ended September 30, 2024 - Defense World
Tortoise Energy Infrastructure Appoints Chairman and Reacts to Legal Decision - Defense World
Tetra Tech Reports Record Fiscal 2024 and Fourth Quarter ResultsOn November 13, 2024, Tetra Tech, Inc. (NASDAQ: TTEK) released its financial results for the fourth fiscal quarter and the fiscal year ended September 29, 2024. According to the report - Defense World
Roth CH Acquisition II Files 8-K Report with SEC Detailing Company Updates and Investor Presentation - Defense World
Capricor Therapeutics Announces Financial Results for Third Quarter 2024 and Strategic DevelopmentsSAN DIEGO, November 13, 2024 (GLOBE NEWSWIRE) — Capricor Therapeutics (NASDAQ: CAPR) recently disclosed its financial outcomes for the third - Defense World
KORU Medical Systems Announces Financial Results for Fiscal Quarter Ended September 30, 2024 - Defense World
Predictive Oncology Inc. Issues Press Release Detailing Financial Results for Q3 2024Predictive Oncology Inc., a leading biopharmaceutical company, released a pivotal press release detailing its financial results for the quarter ending September 30 - Defense World
Flutter Entertainment Announces Launch of Share Repurchase Program - Defense World
374Water Inc. Reports Third Quarter 2024 Results and Business Update - Defense World
Broadwind, Inc. Reports Financial Results for Quarter Ending September 30, 2024 - Defense World
Workhorse Group Reschedules Earnings Call to November 19, 2024 - Defense World
Grace Therapeutics And 2 Other US Penny Stocks To Watch - Simply Wall St
Digital Core REIT Plans EGM for Strategic Acquisition - MSN
Grace Therapeutics Announces Second Fiscal Quarter 2025 Financial Results, Provides Business Update - The Manila Times
Traumatic Brain Injury Clinical Trials 2024: EMA, PDMA, FDA - openPR
SoftBank Corp. Develops 5G L1 Software, Achieving Carrier-grade High Performance and Quality vRAN on NVIDIA Grace Hopper Platform - Yahoo Finance
Vickers Vantage Corp. Receives Notice From The Nasdaq Stock Market Regarding Minimum Bid Price Requirement - Defense World
New York State Teachers Retirement System Cuts Stake in SpartanNash (NASDAQ:SPTN) - Defense World
ADC Therapeutics SA (NYSE:ADCT) Q3 2024 Earnings Call Transcript - MSN
Domaine Serene Celebrates Grace Evenstad’s Legacy Award from ¡Salud! for Extraordinary Contributions to Oregon’s Wine and Vineyard Communities - Yahoo Finance
GRCE: Initiating Coverage – From Confusion to Infusion - MSN
GRCE (Grace Therapeutics) Financial Strength : 9 (As of Jun. 2024) - GuruFocus.com
Corcept Trumps Q3 Earnings & Sales Estimates, Ups '24 Revenue View - MSN
Grace Therapeutics to host virtual KOL event on GTX-104 - Nasdaq
Biopharma Co. Can't Knock Ex-CFO's Bias Suit Out Of Court - Law360
Corcept Therapeutics Announces Third Quarter Financial Results, Positive Results From Phase 3 GRADIENT Trial in Patients With Cushing’s Syndrome and Provides Corporate Update - StockTitan
GRCE (Grace Therapeutics) Cash Flow from Financing : $7.36 Mil (TTM As of Jun. 2024) - GuruFocus.com
Acasti Pharma Inc. Announces Poster Detailing Its GTX-104 STRIVE-ON Trial - Marketscreener.com
Grace Therapeutics to Host Virtual KOL Event on GTx-104 in aneurysmal Subarachnoid Hemorrhage on November 20, 2024 - The Manila Times
OTC Markets Hosts Virtual Investor Presentation with Prashant Kohli, CEO of Grace Therapeutics (Acasti Pharma), with John Vandermosten, Senior Analyst at Zacks SCR - MSN
Grace Expands Polypropylene Operating Capacity in India with Nayara Energy Limited - Yahoo Finance
Acasti Pharma Inc. Announces Resignation of Jean-Marie Canan from Board of Directors and Member of Audit Committee and Governance and Human Resources Committee - Marketscreener.com
Acasti Pharma Insider Bought Shares Worth $1,249,934, According to a Recent SEC Filing - Marketscreener.com
Grace Therapeutics announces name change and new ticker - Investing.com India
Grace Therapeutics Inc (GRCE) 財務データ
Grace Therapeutics Inc (GRCE) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):